News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,197 Results
Type
Article (39629)
Company Profile (250)
Press Release (655318)
Section
Business (204324)
Career Advice (2007)
Deals (35460)
Drug Delivery (93)
Drug Development (81154)
Employer Resources (170)
FDA (16187)
Job Trends (14851)
News (345474)
Policy (32537)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2554)
Academic (1)
Accelerated approval (2)
Adcomms (20)
Allergies (77)
Alliances (49437)
ALS (76)
Alzheimer's disease (1323)
Antibody-drug conjugate (ADC) (100)
Approvals (16173)
Artificial intelligence (211)
Autoimmune disease (10)
Automation (14)
Bankruptcy (357)
Best Places to Work (11652)
BIOSECURE Act (18)
Biosimilars (92)
Biotechnology (177)
Bladder cancer (50)
Brain cancer (24)
Breast cancer (232)
Cancer (1796)
Cardiovascular disease (133)
Career advice (1671)
Career pathing (28)
CAR-T (130)
Cell therapy (374)
Cervical cancer (13)
Clinical research (65529)
Collaboration (701)
Compensation (393)
Complete response letters (18)
COVID-19 (2573)
CRISPR (31)
C-suite (178)
Cystic fibrosis (97)
Data (1716)
Decentralized trials (2)
Denatured (14)
Depression (36)
Diabetes (223)
Diagnostics (6310)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (104)
Drug pricing (94)
Drug shortages (24)
Duchenne muscular dystrophy (65)
Earnings (85767)
Editorial (27)
Employer branding (21)
Employer resources (146)
Events (111498)
Executive appointments (591)
FDA (17157)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (632)
Gene editing (85)
Generative AI (19)
Gene therapy (256)
GLP-1 (659)
Government (4384)
Grass and pollen (4)
Guidances (46)
Healthcare (18824)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (92)
Indications (24)
Infectious disease (2692)
Inflammatory bowel disease (125)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (70)
Interviews (311)
IPO (16494)
IRA (40)
Job creations (3631)
Job search strategy (1422)
Kidney cancer (9)
Labor market (26)
Layoffs (445)
Leadership (14)
Legal (7900)
Liver cancer (69)
Lung cancer (260)
Lymphoma (119)
Machine learning (2)
Management (58)
Manufacturing (245)
MASH (57)
Medical device (13305)
Medtech (13310)
Mergers & acquisitions (19371)
Metabolic disorders (581)
Multiple sclerosis (59)
NASH (16)
Neurodegenerative disease (70)
Neuropsychiatric disorders (23)
Neuroscience (1751)
NextGen: Class of 2025 (6524)
Non-profit (4489)
Northern California (2213)
Now hiring (35)
Obesity (319)
Opinion (200)
Ovarian cancer (61)
Pain (70)
Pancreatic cancer (69)
Parkinson's disease (117)
Partnered (17)
Patents (180)
Patient recruitment (80)
Peanut (45)
People (56987)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20406)
Phase II (28861)
Phase III (21500)
Pipeline (806)
Podcasts (40)
Policy (101)
Postmarket research (2569)
Preclinical (8614)
Press Release (64)
Prostate cancer (84)
Psychedelics (31)
Radiopharmaceuticals (242)
Rare diseases (336)
Real estate (5909)
Recruiting (64)
Regulatory (22032)
Reports (43)
Research institute (2326)
Resumes & cover letters (349)
Rett syndrome (2)
RNA editing (1)
RSV (36)
Schizophrenia (58)
Series A (114)
Series B (68)
Service/supplier (11)
Sickle cell disease (49)
Southern California (1893)
Special edition (13)
Sponsored (28)
Startups (3585)
State (2)
Stomach cancer (12)
Supply chain (56)
The Weekly (25)
United States (19446)
Vaccines (625)
Venture capitalists (34)
Webinars (12)
Weight loss (216)
Women's health (30)
Worklife (13)
Date
Today (169)
Last 7 days (756)
Last 30 days (2947)
Last 365 days (34423)
2025 (5704)
2024 (35288)
2023 (40148)
2022 (51264)
2021 (55793)
2020 (54184)
2019 (46645)
2018 (35117)
2017 (32201)
2016 (31564)
2015 (37642)
2014 (31409)
2013 (26431)
2012 (28614)
2011 (29319)
2010 (27370)
Location
Africa (718)
Alabama (48)
Alaska (7)
Arizona (212)
Arkansas (12)
Asia (37704)
Australia (6183)
California (5042)
Canada (1762)
China (415)
Colorado (230)
Connecticut (240)
Delaware (111)
Europe (81175)
Florida (742)
Georgia (172)
Idaho (57)
Illinois (465)
India (20)
Indiana (275)
Iowa (7)
Japan (126)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (59)
Maryland (771)
Massachusetts (3839)
Michigan (201)
Minnesota (347)
Mississippi (2)
Missouri (71)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (62)
New Jersey (1430)
New Mexico (27)
New York (1442)
North Carolina (877)
North Dakota (7)
Northern California (2213)
Ohio (177)
Oklahoma (13)
Oregon (32)
Pennsylvania (1145)
Puerto Rico (6)
Rhode Island (23)
South America (1096)
South Carolina (13)
South Dakota (1)
Southern California (1893)
Tennessee (83)
Texas (738)
Utah (155)
Virginia (117)
Washington D.C. (55)
Washington State (478)
West Virginia (3)
Wisconsin (44)
695,197 Results for "h3 biomedicine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors
February 11, 2025
·
2 min read
Press Releases
BrainChild Bio, Inc. to Clinically Advance BCB-276, an Autologous B7-H3 Targeting CAR T-cell Therapy for Incurable Pediatric Brain Tumors
January 7, 2025
·
5 min read
Press Releases
Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
February 26, 2025
·
3 min read
Press Releases
TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
February 18, 2025
·
1 min read
Press Releases
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
February 25, 2025
·
1 min read
Biotech Bay
Innovent Provides Interpretation and Updates on Clinical Data from Mazdutide GLORY-1 Study and General Biomedicine Pipeline
Innovent Biologics, Inc. provided interpretation and updates on clinical data from Mazdutide’s GLORY-1 study and its general biomedicine pipeline at an investor conference call on June 25.
June 27, 2024
·
9 min read
Press Releases
Inventiva announces the publication in Biomedicine & Pharmacotherapy of the results from a preclinical study showing improvement of portal hypertension with lanifibranor treatment
February 27, 2025
·
13 min read
Press Releases
Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery
December 18, 2024
·
3 min read
Biotech Beach
Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines
Endeavor BioMedicines, Inc. today announced the closing of a $132.5 million Series C financing, including the conversion of a $5 million convertible instrument.
April 24, 2024
·
4 min read
Genetown
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
Akebia Therapeutics today announced that John Butler , Chief Executive Officer, will participate in the H.C. Wainwright 3rd Annual Kidney Virtual Conference on Monday, July 15, 2024.
June 27, 2024
·
1 min read
1 of 69,520
Next
